论文信息 - REGOMUNE: A phase II study of regorafenib plus avelumab in solid tumors—Results of the non-MSI-H metastatic colorectal cancer (mCRC) cohort. - 字舞流文

REGOMUNE: A phase II study of regorafenib plus avelumab in solid tumors—Results of the non-MSI-H metastatic colorectal cancer (mCRC) cohort.

I. Soubeyran | M. Toulmonde | A. Italiano | C. Bellera | J. Metges | M. Kind | A. Adenis | S. Pernot | C. Gomez-Roca | J. Guégan | S. Cousin | A. Bessede | C. Cantarel | K. Bourcier